Literature DB >> 21930889

Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009.

Anna Baraniak1, Anna Grabowska, Radosław Izdebski, Janusz Fiett, Małgorzata Herda, Katarzyna Bojarska, Dorota Żabicka, Marta Kania-Pudło, Grazyna Młynarczyk, Zofia Żak-Puławska, Waleria Hryniewicz, Marek Gniadkowski.   

Abstract

After the first report in May 2008, the National Reference Center for Susceptibility Testing confirmed 113 cases of infection or colonization by KPC-producing members of the family Enterobacteriaceae in Poland by the end of 2009. The vast majority of patients were found in 18 hospitals; three patients were diagnosed at outpatient clinics. Most of the institutions were in the Warsaw area, including three hospitals with the highest numbers of cases. When available, the data on previous hospitalizations often indicated that these hospitals were the probable acquisition sites; one patient arrived from New York. The group of 119 unique isolates consisted of Klebsiella pneumoniae (n = 114), followed by Klebsiella oxytoca (n = 3), and Escherichia coli (n = 2). The K. pneumoniae isolates were dominated by the clone sequence type 258 (ST258) (n = 111); others were ST11 and ST23. The ST258 group was heterogeneous, with 28 pulsed-field gel electrophoresis (PFGE) subtypes, ∼25 plasmid profiles, and nine β-lactamase patterns differing by KPC variants (KPC-2 mainly), and SHV-12, CTX-M-3, and TEM-1-like enzymes. Plasmids carrying bla(KPC) genes varied in size (~48 to 250 kb), structure, and conjugation potential. Transferable IncFII(K) plasmids of ~110 to 160 kb, probably pKpQIL or its derivatives, were observed in all K. pneumoniae clones and in K. oxytoca. Also prevalent were nontypeable pETKp50-like plasmids of ~50 kb, found in K. pneumoniae ST258 and E. coli isolates (ST93 and ST224). Two K. pneumoniae-E. coli pairs from single patients might represent the in vivo transfer of such plasmids. The striking diversity of KPC producers at the early stage of dissemination could result from several introductions of these bacteria into the country, their multidirectional evolution during clonal spread, and transfer of the plasmids.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21930889      PMCID: PMC3232751          DOI: 10.1128/AAC.05118-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

1.  Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.

Authors:  Anna Baraniak; Radosław Izdebski; Małgorzata Herda; Janusz Fiett; Waleria Hryniewicz; Marek Gniadkowski; Izabela Kern-Zdanowicz; Krzysztof Filczak; Urszula Łopaciuk
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

2.  The spread of Klebsiella pneumoniae carbapenemases: a tale of strains, plasmids, and transposons.

Authors:  L Silvia Munoz-Price; John P Quinn
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

3.  Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.

Authors:  Moran G Goren; Shiri Navon-Venezia; Inna Chmelnitsky; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

4.  Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.

Authors:  Ørjan Samuelsen; Umaer Naseer; Ståle Tofteland; Dag Harald Skutlaberg; Annette Onken; Reidar Hjetland; Arnfinn Sundsfjord; Christian G Giske
Journal:  J Antimicrob Chemother       Date:  2009-02-13       Impact factor: 5.790

Review 5.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.

Authors:  Patrice Nordmann; Gaelle Cuzon; Thierry Naas
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

6.  Genesis of a KPC-producing Klebsiella pneumoniae after in vivo transfer from an imported Greek strain.

Authors:  F Barbier; E Ruppé; P Giakkoupi; L Wildenberg; Jc Lucet; A Vatopoulos; M Wolff; A Andremont
Journal:  Euro Surveill       Date:  2010-01-07

7.  Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.

Authors:  Brandon Kitchel; J Kamile Rasheed; Jean B Patel; Arjun Srinivasan; Shiri Navon-Venezia; Yehuda Carmeli; Alma Brolund; Christian G Giske
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

8.  Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.

Authors:  Thomas D Gootz; Mary Kay Lescoe; Fadia Dib-Hajj; Brian A Dougherty; Wen He; Phyllis Della-Latta; Richard C Huard
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

9.  Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.

Authors:  Spyros Pournaras; Efthimia Protonotariou; Evangelia Voulgari; Ioulia Kristo; Evangelia Dimitroulia; Danai Vitti; Maria Tsalidou; Antonios N Maniatis; Athanassios Tsakris; Danai Sofianou
Journal:  J Antimicrob Chemother       Date:  2009-06-13       Impact factor: 5.790

10.  Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient.

Authors:  Moran G Goren; Yehuda Carmeli; Mitchell J Schwaber; Inna Chmelnitsky; Vered Schechner; Shiri Navon-Venezia
Journal:  Emerg Infect Dis       Date:  2010-06       Impact factor: 6.883

View more
  40 in total

1.  Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Jaroslav Hrabák; Vendula Studentová; Radka Walková; Helena Zemlicková; Vladislav Jakubu; Eva Chudácková; Marek Gniadkowski; Yvonne Pfeifer; John D Perry; Kathryn Wilkinson; Tamara Bergerová
Journal:  J Clin Microbiol       Date:  2012-05-02       Impact factor: 5.948

2.  Complete nucleotide sequence of a blaKPC-harboring IncI2 plasmid and its dissemination in New Jersey and New York hospitals.

Authors:  Liang Chen; Kalyan D Chavda; Nahed Al Laham; Roberto G Melano; Michael R Jacobs; Robert A Bonomo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

3.  First report of KPC-2 Carbapenemase-producing Klebsiella pneumoniae in Japan.

Authors:  Ryoichi Saito; Rieko Takahashi; Etsuko Sawabe; Saho Koyano; Yutaka Takahashi; Mari Shima; Hiroto Ushizawa; Toshihide Fujie; Naoki Tosaka; Yuko Kato; Kyoji Moriya; Shuji Tohda; Naoko Tojo; Ryuji Koike; Tetsuo Kubota
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

4.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry meropenem hydrolysis assay with NH4HCO3, a reliable tool for direct detection of carbapenemase activity.

Authors:  Costas C Papagiannitsis; Vendula Študentová; Radoslaw Izdebski; Olga Oikonomou; Yvonne Pfeifer; Efthimia Petinaki; Jaroslav Hrabák
Journal:  J Clin Microbiol       Date:  2015-02-18       Impact factor: 5.948

5.  Molecular analysis of Acinetobacter baumannii isolates from invasive infections in 2009 in Poland.

Authors:  Radosław Izdebski; Janusz Fiett; Waleria Hryniewicz; Marek Gniadkowski
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

6.  A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone.

Authors:  Amos Adler; Svetlana Paikin; Yelena Sterlin; Josef Glick; Rotem Edgar; Rima Aronov; Mitchell J Schwaber; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2012-07-18       Impact factor: 5.948

7.  Discovery of small-molecule inhibitors of multidrug-resistance plasmid maintenance using a high-throughput screening approach.

Authors:  Katelyn E Zulauf; James E Kirby
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-09       Impact factor: 11.205

8.  Molecular survey of the dissemination of two blaKPC-harboring IncFIA plasmids in New Jersey and New York hospitals.

Authors:  Liang Chen; Kalyan D Chavda; Roberto G Melano; Tao Hong; Albert D Rojtman; Michael R Jacobs; Robert A Bonomo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2014-02-03       Impact factor: 5.191

9.  CG258 Klebsiella pneumoniae isolates without β-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City.

Authors:  Brandon Eilertson; Liang Chen; Audrey Li; Kalyan D Chavda; Bhakti Chavda; Barry N Kreiswirth
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

10.  Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America.

Authors:  Christine Lascols; Gisele Peirano; Meredith Hackel; Kevin B Laupland; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.